TCL Archive DCT Board Gives Concept Approval to “National Drug Discovery Groups,” Suggests Four At $1 Million Each June 11, 1982
TCL Archive Phase III Trial of Imbruvica Halted, Following Increases in Progression-Free Survival January 31, 2014